Insider Transactions in Q1 2021 at Editas Medicine, Inc. (EDIT)
Insider Transaction List (Q1 2021)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 03
2021
|
Jessica Hopfield Director |
BUY
Open market or private purchase
|
Direct |
5,800
+20.35%
|
$261,000
$45.51 P/Share
|
|
Mar 02
2021
|
James C Mullen CEO |
BUY
Open market or private purchase
|
Direct |
25,000
+41.67%
|
$1,150,000
$46.27 P/Share
|
|
Mar 02
2021
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
BUY
Grant, award, or other acquisition
|
Direct |
10,303
+26.39%
|
-
|
|
Feb 09
2021
|
Cynthia Collins CEO |
SELL
Open market or private sale
|
Direct |
1,262
-2.8%
|
$83,292
$66.65 P/Share
|
|
Jan 12
2021
|
Michelle Robertson EVP, CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,568
-7.84%
|
$122,304
$78.27 P/Share
|